British Technology Group

Infobox_Company
company_name = BTG plc
company_
company_type = Public (LSE: [http://www.londonstockexchange.com/en-gb/pricesnews/prices/system/detailedprices.htm?sym=GB0001001592GBGBXSTMM0100159BGC BGC] )
slogan = Developing the difference
foundation = 1991 as British Technology Group Ltd.
key_people = Louise Makin, CEO⁸
Christine Soden, CFO⁸
location = London, Philadelphia, Tokyo
homepage = http://www.btgplc.com
industry = Medical research
products = Licenses and commercialises medical innovations
num_employees = (unavailable)
revenue = £42.7 million (2005)⁸

BTG plc (lse|BGC) is a public limited company specialising in the licensing and commercialisation of medical innovations. It trades as BTG International Inc. in the United States and as BTG International Ltd. in the United Kingdom¹. The latter name arose as the result of the British Technology Group Ltd changing its name on 27 May 1998², having itself been formed by the UK government merging two public-research management bodies.

History

In 1948, the National Research Development Corporation was formed with the purpose of commercialising innovations that arose from publicly funded research³. This was complemented in November 1975 by the establishment of the National Enterprise Board to implement the then-Government's policy of moving public sector industry into commercial private enterprise⁴.

These two organisations were merged by the Government in 1981 to form a new, non-statutory body called the British Technology Group⁵. It acted principally as a technology transfer company, licensing and commercialising the use of publicly-funded developments. The Group was put onto a statutory footing in the "British Technology Group Act, 1991"⁶ with HM Treasury initially being the only shareholder. Subsequently, in March 1992, Cinven arranged a management buy-out from the Government. The company later floated on the London Stock Exchange in 1995³. Three years later, on 27 May 1998, the Group adopted its present name. It now focuses its work on developing and commercialising medical innovations³.

Since acquiring the commercialisation rights to magnetic resonance imaging (MRI) (under a revenue share scheme) in 1983, BTG has come to license a large part of the world market in MRI, including licensees such as General Electric and Philips⁷.

ee also

*Medical research
*National Enterprise Board

References

# [http://www.btgplc.com/miscellaneous/contacts.cfm Contact page for BTGplc giving the various names it trades under] .
# [http://wck2.companieshouse.gov.uk/b7ed5d755a17b5484683cf9921135ebe//compdetails Companies House details] .
# [http://www.btgplc.com/companyoverview/btgshistory.cfm Overview of BTG International's history] .
#cite book|title=The Industry Act, 1975|author=Elizabeth II|year=1975, c. 63|publisher=HM Stationery Office|id = ISBN 0-10-546875-4
# [http://www.bopcris.ac.uk/bopall/ref22099.html Abstract of Department of Trade and Industry report "Monitoring of British Technology Group"] .
#cite book|title=The British Technology Group Act, 1991|author=Elizabeth II|year=1991, c. 66|publisher=The Stationery Office Books|id = ISBN 0-10-546691-3|url=http://www.opsi.gov.uk/acts/acts1991/Ukpga_19910066_en_1.htm
# [http://www.btgplc.com/companyoverview/casestudies/MRI.cfm Case study of BTG's MRI licensing] .
# [http://www.btgplc.com/newsevents/article.cfm?id=377 Preliminary financial results for 2005] .

External links

* [http://www.btgplc.com BTG Plc's website]

__NOTOC__